49. Restoring connections for neurodegenerative diseases, Leen Kawas, CEO, Athira Pharma

episode

Biotech 2050 Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Oura Delays IPO Over Market Uncertainty 2 min · 29 Sep 2026 · WSJ Minute Briefing

Win Brooke's Bucks (9/29/26) 11 min · 29 Sep 2026 · Brooke and Jeffrey

Ex-Disney CEO BREAKS SILENCE on Bob Iger & The Truth About Disney | PBD Podcast #864 1h 59m · 29 Sep 2026 · PBD Podcast

A Relaxing Visit to Ek Balam 44 min · 29 Sep 2026 · Get Sleepy: stories for sleep

Ep. 2070 - Republican Campaign Ad Brutalizes Lazy White Men 51 min · 29 Sep 2026 · The Michael Knowles Show

The Dollar-Store Hour: Why Doing It Yourself is Costing You Millions 3 min · 29 Sep 2026 · The Level Up Podcast w/ Paul Alex

Report any issue

Source

Recorded10 Mar 2021

Publisherfeeds.soundcloud.com ↗

Handlerec:2866966

Show notes

Leen Kawas, Ph.D., has served as our chief executive officer and as a member of our board of directors since January 2014. Previously, Dr. Kawas served as our vice president. Dr. Kawas serves on multiple boards, including the Washington Governor’s Life Science Advisory Board, Scientific Review Board for the Alzheimer’s Drug Discovery Foundation, and Alzheimer’s Association – Washington Chapter Board. She also served as the co-chair of the International Alzheimer's Association Business Consortium. Dr. Kawas earned a Ph.D. in molecular pharmacology from Washington State University in 2011 and a pharmacy degree from the University of Jordan in 2008.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in